These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8034203)
1. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability. MacLennan WJ; Wilson J; Rattenhuber V; Dikland WJ; Vanderdonckt J; Moriau M Gerontology; 1994; 40(1):45-52. PubMed ID: 8034203 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency. Poynard T; Valterio C Vasa; 1994; 23(3):244-50. PubMed ID: 7975870 [TBL] [Abstract][Full Text] [Related]
3. The effect of hydroxyethylrutosides on capillary filtration in moderate venous hypertension: a double blind study. Renton S; Leon M; Belcaro G; Nicolaides AN Int Angiol; 1994 Sep; 13(3):259-62. PubMed ID: 7822903 [TBL] [Abstract][Full Text] [Related]
4. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel]. Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532 [TBL] [Abstract][Full Text] [Related]
5. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969 [TBL] [Abstract][Full Text] [Related]
6. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Stuard S; Corsi M Angiology; 2005; 56(2):165-72. PubMed ID: 15793606 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function. Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872 [TBL] [Abstract][Full Text] [Related]
8. Doxium 500 in chronic venous insufficiency: a double-blind placebo controlled multicentre study. Widmer L; Biland L; Barras JP Int Angiol; 1990; 9(2):105-10. PubMed ID: 2254672 [TBL] [Abstract][Full Text] [Related]
9. A systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency. Aziz Z; Tang WL; Chong NJ; Tho LY J Clin Pharm Ther; 2015 Apr; 40(2):177-85. PubMed ID: 25630350 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings. Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630 [TBL] [Abstract][Full Text] [Related]
11. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency]. Barbarino C; Pezzangora V Vasa Suppl; 1989; 27():120. PubMed ID: 2623482 [No Abstract] [Full Text] [Related]
12. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study. Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162 [TBL] [Abstract][Full Text] [Related]
13. [A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions]. Nocker W; Diebschlag W; Lehmacher W Vasa; 1989; 18(3):235-8. PubMed ID: 2678805 [TBL] [Abstract][Full Text] [Related]